Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Antigen Express initiates clinical trials in Her-2/neu positive breast cancer
April 21st, 2005
Generex Biotechnology Corp. (GNBT) announced that patient enrollment had begun for trials with a therapeutic vaccine for breast cancer developed by its wholly owned subsidiary Antigen Express. The compound, AE37, is being tested with LTC George Peoples, MD, Medical Corps, U.S. Army at the Walter Reed Army Medical Center (WRAMC), in conjunction with the Clinical Breast Care Project (CBCP). The CBCP is a congressionally mandated civilian-military collaboration between WRAMC, the Uniformed Services University of the Health Sciences, the Windber Research Institute (Windber, Pennsylvania), and The Henry M Jackson Foundation for the Advancement of Military...
Source: Women's Health Weekly (2005-04-21)
|
